Unknown

Dataset Information

0

The Functional Effect of Repeated Cryopreservation on Transduced CD34+ Cells from Patients with Thalassemia.


ABSTRACT: Stable gene marking and effective engraftment of gene-modified CD34+ hematopoietic stem cells is a prerequisite for gene therapy success but may be challenged by the inevitable cryopreservation of the final product prior to extensive quality assurance testing. We investigated the ?-globin gene transfer potency in fresh and cryopreserved CD34+ cells from mobilized patients with ?-thalassemia, as well as the qualitative impact of repeated freeze/thaw cycles on the functionality of cultured and unmanipulated CD34+ cells in terms of engrafting capacity in a xenotransplantation model, under partial myeloablation. Cells transduced fresh or after one freeze-thaw cycle yielded similar clonogenic and gene transfer frequencies. Repeated cryopreservation cycles did not affect the transduction rates whereas either one or two freeze-thaw cycles of cultured-but not of unmanipulated-cells significantly reduced their clonogenicity. No differences in the engrafting potential of gene-corrected cells subjected to either none or up to two cryopreservation cycles, were encountered post xenotransplantation. Overall, we assessed the gene transfer efficiency, clonogenicity and engrafting capacity of cryopreserved CD34+ cells and the impact of repeated freeze/thaw cycles in their performance. These observations may prove essential in the design of gene therapy trials, considerably facilitating their logistics.

SUBMITTER: Karponi G 

PROVIDER: S-EPMC6206548 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Functional Effect of Repeated Cryopreservation on Transduced CD34<sup>+</sup> Cells from Patients with Thalassemia.

Karponi Garyfalia G   Papayanni Penelope-Georgia PG   Zervou Fani F   Bouinta Asimina A   Anagnostopoulos Achilles A   Yannaki Evangelia E  

Human gene therapy methods 20180830 5


Stable gene marking and effective engraftment of gene-modified CD34<sup>+</sup> hematopoietic stem cells is a prerequisite for gene therapy success but may be challenged by the inevitable cryopreservation of the final product prior to extensive quality assurance testing. We investigated the β-globin gene transfer potency in fresh and cryopreserved CD34<sup>+</sup> cells from mobilized patients with β-thalassemia, as well as the qualitative impact of repeated freeze/thaw cycles on the functionali  ...[more]

Similar Datasets

| S-EPMC3704632 | biostudies-literature
| S-EPMC3105013 | biostudies-literature
| S-EPMC3551902 | biostudies-literature
2017-04-28 | GSE70219 | GEO